Combined with the fact that serum chemerin levels were inversely correlated to GM-CSF and IL-6 expression levels in patients with HCC, the study suggested that chemerin may have a negative regulatory role for these two cytokines (82). The gene discussed is RARRES2; the disease is hepatocellular carcinoma.